Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.66 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.55 |
| ▸ | PSEN2 | P49810 | 4/20 | 0.55 |
| ▸ | APH1B | Q8WW43 | 4/20 | 0.55 |
| ▸ | NCSTN | Q92542 | 4/20 | 0.55 |
| ▸ | APH1A | Q96BI3 | 4/20 | 0.55 |
| ▸ | PSENEN | Q9NZ42 | 4/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CTSG | P08311 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2219782 | 1.00 | HSD11B1 (0.66) | HSD11B1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL2222104 | 1.00 | HSD11B1 (0.66) | HSD11B1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL2220391 | 0.94 | PSEN1 (0.60) | HSD11B1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8273917 | 0.84 | CYP3A4 (0.56) | HSD11B1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL2220964 | 0.81 | PSEN1 (0.70) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL12786689 | 0.80 | HSD11B1 (1.00) | HSD11B1ACHE | |
| SCHEMBL2221432 | 0.79 | PSEN1 (0.72) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL916819 | 0.78 | PSEN1 (0.57) | HSD11B1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL19640887 | 0.78 | PSEN1 (0.57) | HSD11B1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8273877 | 0.77 | PSEN1 (0.56) | PSEN1PSEN2APH1BNCSTNAPH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110178119-A1 | Bridged N-Bicyclic Sulfonamido Inhibitors of Gamma Secretase | ELAN PHARMACEUTICALS, INC. (US) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178119-A1 | Bridged N-Bicyclic Sulfonamido Inhibitors of Gamma Secretase | BACE1, BACE2, PSEN1 | HSD11B1 544/4885PSEN1 3/4885PSEN2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.